sonic healthcare

Nikko Asset Management Australia

The healthcare industry is always evolving, and new therapies drive ongoing growth over and above the growth from the ageing demographic. However, it’s important that investors recognise that the sector’s growth doesn’t necessarily translate equally to each participant, for example, when new therapies displace incumbents. Three particular drivers of change... Show More

Scott Power

Sonic 1H16 results were in line with our expectations, with solid underlying earnings growth driven by ex-Australia ops, somewhat overcoming well-flagged government policies that negatively impacted domestic businesses. Importantly, strong organic laboratory growth, profit enhancements across the domestic front, and gains from recent acquisitions and FX tailwinds, reiterate the outlook... Show More

Livewire Equities

Disruption on the way for Sonic Healthcare. Sonic is the largest pathology company in Australia and Germany, and the third largest in the US. The business generated $3.5 billion in revenue and $340 million in NPAT in 2013 and employs thousands of pathologists, medical scientists and technicians. You wouldn't think... Show More